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Introduction: Perivascular stem cells (PSCs) are a rare population of multipotent progenitor 
cells with the capacity to self-renew and differentiate into mesenchymal and neuroectodermal 
lineages. Indeed, recently it has been shown that PSCs play an important role in repairing of the 
nervous tissue during cerebral ischemia, as they can differentiate into neurons and glial cells in the 
hippocampal subgranular zone of experimental animals. Thus, these data indicate that PSCs can be 
promising candidates for treatment of ischemic stroke. In this regard, the purpose of our study was 
to examine the effect of conditioned medium derived from PSCs on recovery of neurological 
function after ischemic stroke in rats. 
Methods: Rat PSCs were isolated from subcutaneous adipose tissue by a FACS Aria cell 
sorter using antibodies against CD146 and CD34 and expanded in a-MEM supplemented with 10% 
fetal bovine serum. The conditioned medium was collected after incubation with PSCs (passage 3) 
for 24 hours. Adult male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion 
(MCAO) followed by femoral vein injection of 150 ug protein from PSC-derived conditioned 
medium or an equal volume of vehicle phosphate-buffered saline 24 hours (PBS) later. For 
neurological recovery evaluation, a walking beam test was carried out. Animals were trained prior 
to МСАО, and neurological deficits were evaluated at 1, 7, 14 and 28 d after IV injection of the 
conditioned medium. Neurogenesis was evaluated with histological method. 
Results: It was observed that intravenous injection of conditioned medium of PSCs improved 
neurological outcome but did not reduce the ischemic lesion of the brain. Histological analysis 
revealed that conditioned medium treatment increased neurogenesis and attenuated microglia 
infiltration in stroke rats compared with PBS-treated controls. In addition, number of blood 
capillaries was significantly increased along the ischemic boundary zone of the cortex and striatum 
in rats treated with conditioned medium of PSCs. 
Conclusion: Thus, our results suggest that intravenous administration of conditioned medium 
of PSCs can improve functional recovery and enhance neurogenesis and represents a novel 
treatment for ischemic stroke. 
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